MedPath

Comparison between Rocuronium bromide and Succinylcholine chloride in Rapid sequence induction and intubation in emergency cases

Phase 2/3
Not yet recruiting
Conditions
Diseases of the digestive system,
Registration Number
CTRI/2025/04/085595
Lead Sponsor
Shabiba Yashmin Haque
Brief Summary

Rocuronium bromide versus Succinylcholine chloride in rapid sequence induction and intubation in emergency cases will be studied in our study.

The aim of our study is to compare the ease of intubation of succinylcholine chhloride and rocuronium bromide at 60 seconds for rapid sequence induction and intubation in emergency cases.

Primary objective: Comparison of intubating conditions of Succinylcholine chloride and Rocuronium bromide during laryngoscopy at 60 seconds.

Secondary objective: Comparison of adverse effects if any, at the time of laryngoscopy in both the groups such as:

bradycardia, tachycardia, laryngospasm, arrythmia

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
336
Inclusion Criteria

1.Availability of informed consent 2.Emergency cases with ASA grading 1,2,3 3.Emergency cases with Mallampati score 1,2,3.

Exclusion Criteria
  • Non availability of consent 2.
  • Patients with history of allergy to the drugs used in this study 3.
  • Patients with prolonged immobilization, burn or crush injury.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Comparision of intubating conditions of succinylcholine chloride and rocuronium bromide during laryngoscopy at 60 secondsAt 60 seconds of laryngoscopy, the intubating conditions of Rocuronium bromide and Succinylcholine chloride will be compared
Secondary Outcome Measures
NameTimeMethod
Comparision of adverse effects if any,at the time of laryngoscopy in both the groups-1.Bradycardia

Trial Locations

Locations (1)

Gauhati Medical College and Hospital

🇮🇳

Kamrup, ASSAM, India

Gauhati Medical College and Hospital
🇮🇳Kamrup, ASSAM, India
Dr Shabiba Yashmin Haque
Principal investigator
08638160500
shabibay2611@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.